National Heart, Lung, and Blood Institute
Michael M. Engelgau, M.D., M.S., is deputy director of the Center for Translation Research and Implementation Science (CTRIS) at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).
As deputy director of CTRIS, Dr. Engelgau helps to lead an integrative, trans-Institute effort to advance the translation of scientific discoveries in heart, lung, and blood diseases research to clinical and public health practice nationally and globally. CTRIS will address its mission by investing in research that shows how fundamental scientific discoveries and interventions of proven effectiveness can best be applied in hospitals, homes, worksites, and the community at large to maximize population health impact.
Dr. Engelgau’s professional experience includes 24 years of public service at the Centers for Disease Control and Prevention (CDC) and four years of service at the World Bank. He is trained in both internal and preventive medicine and has completed the CDC’s Epidemic Intelligence Service program. His career has focused on developing research programs and policies that translate science into practice for prevention and control of non-communicable diseases.
Before joining the NHLBI, Dr. Engelgau was the director of U.S. CDC’s China Country Office and director of Non-Communicable Disease (NCD) activities in Beijing, China. In this role he was responsible for the entire CDC portfolio of communicable diseases and NCDs and led management of the portfolio for NCD disease research and capacity building collaborations between CDC and China’s Centers for Disease Control. In addition to his public service at CDC, Dr. Engelgau has been a member of the United States Public Health Service Commission Corp since 1990. In 1999 he was nominated for the CDC Shepard Award, the highest scientific award at the CDC.